Table 2.
Group | Total (N = 92) | ASD (N = 54) | TDC (N = 38) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Relative SCFA |
AA | PA | BA | AA | PA | BA | AA | PA | BA | |
Faith_pd | rs | −0.185 | 0.000 | 0.318 | −0.006 | −0.188 | 0.216 | −0.428 | 0.264 | 0.490 |
p | 0.078 | 0.997 | 0.002 * | 0.964 | 0.174 | 0.117 | 0.008 * | 0.110 | 0.002 * | |
Observed OTUs | rs | −0.101 | −0.011 | 0.253 | 0.083 | −0.154 | 0.103 | −0.319 | 0.169 | 0.438 |
p | 0.340 | 0.917 | 0.015 * | 0.551 | 0.267 | 0.457 | 0.051 | 0.310 | 0.006 * |
ASD, autism spectrum disorder; TDC, typical developing children; SCFA, short-chain fatty acid; AA, acetic acid; PA, propionic acid; BA, butyric acid. rs indicates correlation coefficient, * p < 0.05.